Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cyclofluidic Announces its Automated Chemical Synthesis-To-Screen Process for Drug Discovery

Published: Wednesday, March 16, 2011
Last Updated: Wednesday, March 16, 2011
Bookmark and Share
Researchers synthesize and test a greater range of potential new medicines in a considerably shorter time frame.

Cyclofluidic‘s technology platform will significantly accelerate the drug discovery process, by giving researchers a platform to synthesize and test a greater range of potential new medicines in a considerably shorter time frame. It is envisaged that this new technology will radically transform drug discovery by improving both the efficiency and the overall cost to the industry.

Cyclofluidic has successfully demonstrated this fully integrated approach encompassing chemical synthesis of a pharmaceutically relevant molecule through to the generation of high quality target screening data. Cyclofluidic’s Chief Operating Officer David Parry commented “Achieving this scientific milestone represents a key stage in the evolution of Cyclofluidic.

We have demonstrated a fully integrated and automated approach to the generation of structure activity data which underpins modern drug discovery. The results illustrate the potential of the Cyclofluidic integrated approach to deliver next generation medicinal chemistry. I am delighted that we have been able to achieve such significant continued progress.”

“The interface between chemical synthesis and biological measurement is an exciting one, and tightening the connection between the two is a key challenge. This result shows that Cyclofluidic are making excellent progress in developing their internal capabilities” said David Klug, Professor of Chemical Biophysics and Head of the Imperial College Institute for Chemical Biology and chair of Cyclofluidic’s Scientific Advisory Board.

Currently, it takes between 12-15 years and a cost of up to US$1 billion to develop a new medicine. A key element of early stage pharmaceutical research is the synthesis and screening of new molecules as potential medicines against therapeutic targets. The research and development activities being undertaken within Cyclofluidic are expected to impact significantly on the timelines for the optimization of potential molecules.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Blood-brain Barrier on a Chip
Researchers from Vanderbilt University have developed a microfluidic device to study the blood-brain barrier.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
Making Every Cell Matter
New method for encapsulating single cells within microgels could boost efficacy of cell-based therapies and tissue engineering.
Modelling Cigarette Effects with Airway-on-a-Chip
An instrument that smokes cigarettes like a human, and delivers whole smoke to the air space of microfluidic human airway chips, enables new insights into how non-smokers and COPD patients respond to smoke.
Robotic Cleaning Technique Could Automate Neuroscience Research
New robotic cleaning technique allows pipettes used in patch-clamping to be re-used up to 11 or more times.
Lab-on-a-Chip to Help Detect Cancer
In this podcast, we speak to Gustavo Stolovitsky to learn about his career and the work he is doing at IBM Research.
First Entirely 3D-printed Organ-on-a-Chip with Integrated Sensors
New approach to manufacturing may allow researchers to rapidly design organs-on-chips that match the properties of a specific disease or individual patient's cells.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!